Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma After Attempted Portal Vein Embolization in 25 Patients

2009 ◽  
Vol 193 (5) ◽  
pp. W446-W451 ◽  
Author(s):  
Bo-Kyeong Kang ◽  
Jin Hyoung Kim ◽  
Kwang Mi Kim ◽  
Gi-Young Ko ◽  
Hyun-Ki Yoon ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Transcatheter Arterial Chemoembolization ◽  
Arterial Chemoembolization

scholarly journals Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Zhiying Shao ◽  
Xin Liu ◽  
Chanjuan Peng ◽  
Liping Wang ◽  
Dong Xu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Transcatheter Arterial Chemoembolization ◽  
Combined Treatment ◽  
Chemotherapeutic Agents ◽  
Main Body ◽  
Term Survival ◽  
Arterial Chemoembolization

Abstract Background Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial chemoembolization. Main body Theoretically, portal vein embolization combined with transcatheter arterial chemoembolization may bring a breakthrough in the therapeutic effect of hepatocellular carcinoma. The feasibility, efficacy, long-term survival benefits, and side effects of the combined treatment have been explored in previous studies. Chemotherapeutic agents may also be added in the portal vein embolization procedure to further improve the treatment response. Conclusion In this study, we review the existing data and studies on the combined treatment in patients with hepatocellular carcinoma and provide an overall view of the strategy.

Sign in / Sign up

Export Citation Format

Share Document